{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T10:56:46Z","timestamp":1775473006910,"version":"3.50.1"},"reference-count":38,"publisher":"Medical Association of Zenica-Doboj","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicinski Glasnik"],"published-print":{"date-parts":[[2017,8,1]]},"abstract":"<jats:p>&amp;lt;p&amp;gt;&amp;lt;strong&amp;gt;Aim&amp;lt;br \/&amp;gt;&amp;lt;\/strong&amp;gt; To determine the serum levels of matrix metalloproteinase 9 (MMP-9) concentration and their association with the stage and histopathologic sizes of colorectal cancer (CRC). &amp;lt;br \/&amp;gt;&amp;lt;strong&amp;gt;Methods&amp;lt;br \/&amp;gt;&amp;lt;\/strong&amp;gt; One hundred and two patients with clinically diagnosed and histologically confirmed colorectal cancer ready for surgical treatment were included in the study. In each patient, preoperative peripheral venous blood samples were taken for determination of the concentration of MMP-9 using ELISA immunoassay test. Resected tumour specimens were studied pathologically according to the criteria of the TNM classification. All patients were divided into groups according to the TNM classification. The control group presented 30 subjects of the appropriate age and gender with no family history of cancer, clinical signs of malignancy or inflammatory bowel disease. &amp;lt;br \/&amp;gt;&amp;lt;strong&amp;gt;Results&amp;lt;br \/&amp;gt;&amp;lt;\/strong&amp;gt; The serum levels of MMP-9 were progressively increased in patients with CRC reaching the highest value in the fourth stage of CRC. It was also confirmed that the serum concentrations of MMP-9 were significantly higher in patients with pericolonic lymph nodes involvement compared to the patients with no involvement of lymph nodes, 456.4 (445.9-464.7) ng\/mL vs. 438.4 (418.4-447.8) ng\/mL (p&amp;amp;lt;0.001). Significantly higher serum levels of MMP-9 were found in the patients with metastatic CRC, 458.5 (452.0-468.1) ng\/mL compared with the CRC patients without metastasis, 445.8 (436.9-456.5) ng\/mL (p&amp;amp;lt;0.001). &amp;lt;strong&amp;gt;Conclusion&amp;lt;br \/&amp;gt;&amp;lt;\/strong&amp;gt; It was confirmed that serum concentration of MMP-9 presented the significant independent risk factors for the progression of CRC.&amp;lt;\/p&amp;gt;<\/jats:p>","DOI":"10.17392\/908-17","type":"journal-article","created":{"date-parts":[[2024,4,21]],"date-time":"2024-04-21T10:20:46Z","timestamp":1713694846000},"page":"229-235","source":"Crossref","is-referenced-by-count":2,"title":["The association between the serum levels of matrix metalloproteinase 9 and colorectal cancer"],"prefix":"10.17392","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3675-4173","authenticated-orcid":false,"given":"Ismar","family":"Ra\u0161i\u0107","sequence":"first","affiliation":[{"name":"Clinical Center of the University of Sarajevo","place":["Sarajevo,Bosnia and Herzegovina"],"department":["Clinic for General and Abdominal Surgery"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azra","family":"Ra\u0161i\u0107","sequence":"additional","affiliation":[{"name":"Clinical Center of the University of Sarajevo","place":["Sarajevo,Bosnia and Herzegovina"],"department":["Clinic for Oncology"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Goran","family":"Ak\u0161amija","sequence":"additional","affiliation":[{"name":"Clinical Center of the University of Sarajevo","place":["Sarajevo,Bosnia and Herzegovina"],"department":["Clinic for General and Abdominal Surgery"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Svjetlana","family":"Radovi\u0107","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Sarajevo","place":["Sarajevo,Bosnia and Herzegovina"],"department":["Department of Pathology"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ned\u017ead","family":"\u0160ehovi\u0107","sequence":"additional","affiliation":[{"name":"Regional Hospital Haugesund","place":["Haugesund,Norway"],"department":["Gastro Surgical Department"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"49509","published-online":{"date-parts":[[2017,8,1]]},"reference":[{"key":"ref1","first-page":"7","article-title":"Cancer statistics","author":"RSiegelR","year":"2016. 2016","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, \n2016. CA Cancer J Clin 2016; 66:7-30.","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1093\/annonc\/mdv001","article-title":"European cancer mortality predictions for the year 2015: does lung cancer have the highest death rate in EU women?","author":"MMalvezziM","year":"2015","unstructured":"Malvezzi M, Bertuccio P, Rosso T, Rota M, Levi F, La \nVecchia C, Negri E. European cancer mortality pre-\ndictions for the year 2015: does lung cancer have the \nhighest death rate in EU women? Ann Oncol 2015; \n26:779-86.","journal-title":"Ann Oncol"},{"key":"ref3","first-page":"759","article-title":"A genetic model for colorectal tumorigenesis","author":"EFearonnE","year":"1990","unstructured":"Fearonn ER, Vogelstein B. A genetic model for colo-\nrectal tumorigenesis. Cell 1990; 61:759-67.","journal-title":"Cell"},{"key":"ref4","first-page":"1","article-title":"Free radicals, metals and antioxidants in oxidative stress-induced cancer","author":"MValkoM","year":"2006","unstructured":"Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur \nM. Free radicals, metals and antioxidants in oxida-\ntive stress-induced cancer. Chem Biol Interac 2006; \n160:1-40.","journal-title":"Chem Biol Interac"},{"key":"ref5","first-page":"2646","article-title":"Activity of superoxide dismutase, catalase, glutathione peroxidase, and glutathione reductase in different stages of colorectal carcinoma","author":"KGop\u010devi\u0107K","year":"2013","unstructured":"Gop\u010devi\u0107 KR, Rov\u010danin BR, Tati\u0107 SB, Krivokapi\u0107 \nZV, Gaji\u0107 MM, Dragutinovi\u0107 VV. Activity of supe-\nroxide dismutase, catalase, glutathione peroxidase, \nand glutathione reductase in different stages of colo-\nrectal carcinoma. Dig Dis Sci 2013; 58:2646-52.","journal-title":"Dig Dis Sci"},{"key":"ref6","first-page":"13246","article-title":"Impact of proteolytic enzymes in colorectal cancer development and progression","author":"LHersz\u00e9nyiL","year":"2014","unstructured":"Hersz\u00e9nyi L, Barab\u00e1s L, Hritz I, Istv\u00e1n G, Tulassay \nZ. Impact of proteolytic enzymes in colorectal cancer \ndevelopment and progression. World J Gastroenterol \n2014; 20:13246-57.","journal-title":"World J Gastroenterol"},{"key":"ref7","first-page":"919","article-title":"The history of matrix metalloproteinases: milestones, myths, and misperceptions","author":"RIyerR","year":"2012","unstructured":"Iyer RP, Patterson NL, Fields GB, Lindsey ML. The \nhistory of matrix metalloproteinases: milestones, \nmyths, and misperceptions. Am J Physiol Heart Circ \nPhysiol 2012; 303:H919-30.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref8","first-page":"5287","article-title":"Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer","author":"RRoyR","year":"2009","unstructured":"Roy R, Yang J, Moses MA. Matrix metalloproteinases \nas novel biomarkers and potential therapeutic targets \nin human cancer. J Clinl Oncol 2009; 27:5287-97.","journal-title":"J Clinl Oncol"},{"key":"ref9","first-page":"133","article-title":"Matrix metalloproteinase-2 and -7 expression in colorectal cancer","author":"SHongS","year":"2011","unstructured":"Hong SW, Kang YK, Lee B, Lee WY, Jang YG, Paik \nIW, Lee H. Matrix metalloproteinase-2 and -7 expre-\nssion in colorectal cancer. J Korean Soc Coloproctol \n2011; 27:133-9.","journal-title":"J Korean Soc Coloproctol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/LBR.0000000000000094","article-title":"Matrix metalloproteinase-9 expression in lung cancer patients and its relation to serum MMP-9 activity, pathologic type, and prognosis","author":"MEl-BadrawyM","year":"2014","unstructured":"El-Badrawy MK, Yousef AM, Shaalan D, Elsama-\nnoudy AZ. Matrix metalloproteinase-9 expression in \nlung cancer patients and its relation to serum MMP-9 \nactivity, pathologic type, and prognosis. J Broncho-\nlogy Interv Pulmonol 2014; 21:327-34.","journal-title":"J Bronchology Interv Pulmonol"},{"key":"ref11","first-page":"613","article-title":"Clinical significance of the measurements of serum matrix metalloproteinase-9 and its inhibitor (tissue inhibitor of metalloproteinase-1) in patients with pancreatic cancer: metalloproteinase-9 as an independent prognostic factor","author":"BMroczkoB","year":"2009","unstructured":"Mroczko B, Lukaszewicz-Zajac M, Wereszczynska-\nSiemiatkowska U, Groblewska M, Gryko M, Kedra \nB, Jurkowska G, Szmitkowski M. Clinical signifi-\ncance of the measurements of serum matrix metallo-\nproteinase-9 and its inhibitor (tissue inhibitor of me-\ntalloproteinase-1) in patients with pancreatic cancer: \nmetalloproteinase-9 as an independent prognostic \nfactor. Pancreas 2009; 38: 613-8.","journal-title":"Pancreas"},{"key":"ref12","first-page":"67","article-title":"Combined detection of serum matrix metalloproteinase 9, acetyl heparinase and cathepsin L in diagnosis of ovarian cancer","author":"WZhangW","year":"2012","unstructured":"Zhang W, Hu X-x, Yang X-z, Wang Q, Cheng H, \nWang S-m, Yan-ling Hu, Yang Z-j, Li L. Combined \ndetection of serum matrix metalloproteinase 9, acetyl \nheparinase and cathepsin L in diagnosis of ovarian \ncancer. Chin J Cancer Res 2012; 24: 67-71.","journal-title":"Chin J Cancer Res"},{"key":"ref13","first-page":"327","article-title":"Type IV collagenase (matrix metalloproteinase-2 and -9) in prostate cancer","author":"LZhangL","year":"2004","unstructured":"Zhang L, Shi J, Feng J, Klocker H, Lee C, Zhang \nJ. Type IV collagenase (matrix metalloproteinase-2 \nand -9) in prostate cancer. Prostate Cancer Prostatic \nDis 2004; 7:327-32.","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"ref14","article-title":"FUNDING No specific funding was received for this study. TRANSPARENCY DECLARATIONS Competing interests: none to declare","unstructured":"FUNDING \nNo specific funding was received for this study. \nTRANSPARENCY DECLARATIONS \nCompeting interests: none to declare."},{"key":"ref15","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1186\/1471-2407-9-390","article-title":"Circulating levels of matrix metalloproteinase-9 (MMP-9), neutrophil gelatinase-associated lipocalin (NGAL) and their complex MMP-9\/ NGAL in breast cancer disease","author":"XProvatopoulouX","year":"2009","unstructured":"Provatopoulou X, Gounaris A, Kalogera E, Zagouri \nF, Flessas I, Goussetis E, Nonni A, Papassotiri-\nou I, Zografos G. Circulating levels of matrix metal-\nloproteinase-9 (MMP-9), neutrophil gelatinase-asso-\nciated lipocalin (NGAL) and their complex MMP-9\/ \nNGAL in breast cancer disease. BMC Cancer 2009; \n9:390.","journal-title":"BMC Cancer"},{"key":"ref16","first-page":"1422","article-title":"YKL-40 and matrix metalloproteinase-9 as potential serum biomarkers for patients with high-grade gliomas","author":"AHormigoA","year":"2017","unstructured":"Hormigo A, Gu B, Karimi S, Riedel E, Panageas \nKS, Edgar MA, Tanwar MK, Rao JS, Fleisher M, \nDeAngelis LM, Holland EC. YKL-40 and matrix me-\ntalloproteinase-9 as potential serum biomarkers for \npatients with high-grade gliomas. Clin Cancer Res \n2017; 23:1422-31.","journal-title":"Clin Cancer Res"},{"key":"ref17","first-page":"13240","article-title":"The behavior of matrix metalloproteinases and their inhibitors in colorectal cancer","author":"LHersz\u00e9nyiL","year":"2012","unstructured":"Hersz\u00e9nyi L, Hritz I, Lakatos G, Varga MZ, Tulassay \nZ. The behavior of matrix metalloproteinases and the-\nir inhibitors in colorectal cancer. Int J Mol Sci 2012; \n13:13240-63.","journal-title":"Int J Mol Sci"},{"key":"ref18","first-page":"1049","article-title":"Expression and prognostic value of matrix metalloproteinase-7 in colorectal cancer","author":"BYangB","year":"2012","unstructured":"Yang B, Su K, Gao J, Rao Z. Expression and progno-\nstic value of matrix metalloproteinase-7 in colorectal \ncancer. Asian Pac J Cancer Prev 2012; 13:1049-52.","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref19","first-page":"971","article-title":"Elevated serum matrix metalloproteinase 9 (MMP-9) concentration predicts the presence of colorectal neoplasia in symptomatic patients","author":"NHurstN","year":"2007","unstructured":"Hurst NG, Stocken DD, Wilson S, Keh C, Wakelam \nMJ, Ismail T. Elevated serum matrix metalloprotei-\nnase 9 (MMP-9) concentration predicts the presence \nof colorectal neoplasia in symptomatic patients. Br J \nCancer 2007; 97:971-7.","journal-title":"Br J Cancer"},{"key":"ref20","first-page":"1431","article-title":"Serum matrix metalloproteinase 9 and colorectal neoplasia: a community-based evaluation of a potential diagnostic test","author":"SWilsonS","year":"2012","unstructured":"Wilson S, Damery S, Stocken DD, Dowswell G, Hol-\nder R, Ward ST, Redman V, Wakelam MJ, James \nJ, Hobbs FD, Ismail T. Serum matrix metalloprotei-\nnase 9 and colorectal neoplasia: a community-based \nevaluation of a potential diagnostic test. Br J Can-\ncer 2012; 106:1431-8.","journal-title":"Br J Cancer"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.cell.2010.03.015","article-title":"Matrix metalloproteinases: regulators of the tumor microenvironment","author":"KKessenbrockK","year":"2010","unstructured":"Kessenbrock K, Plaks V, Werb Z. Matrix metallopro-\nteinases: regulators of the tumor microenvironment. \nCell 2010; 141:52-67.","journal-title":"Cell"},{"key":"ref22","first-page":"318","article-title":"Matrix metalloproteinase-9 is associated with relapse and prognosis of patients with colorectal cancer","author":"DChuD","year":"2012","unstructured":"Chu D, Zhao Z, Zhou Y, Li Y, Li J, Zheng J, Zhao \nQ, Wang W. Matrix metalloproteinase-9 is associated \nwith relapse and prognosis of patients with colorectal \ncancer. Ann Surg Oncol 2012; 19:318-325.","journal-title":"Ann Surg Oncol"},{"key":"ref23","first-page":"993","article-title":"Serum levels of matrix metalloproteinase-2 and -9 and conventional tumor markers (CEA and CA 19-9) in patients with colorectal and gastric cancers","author":"MEmaraM","year":"2009","unstructured":"Emara M, Cheung P-Y, Grabowski K, Sawicki G, \nWozniak M. Serum levels of matrix metalloprotei-\nnase-2 and -9 and conventional tumor markers (CEA \nand CA 19-9) in patients with colorectal and gastric \ncancers. Clin Chem Lab Med 2009; 47:993-1000.","journal-title":"Clin Chem Lab Med"},{"key":"ref24","first-page":"104","article-title":"Pathology and Genetics of Tumours of the Digestive System","author":"SHamiltonS","year":"2000","unstructured":"Hamilton SR, Aaltonen LA. (Eds). Pathology and Ge-\nnetics of Tumours of the Digestive System. In: Klei-\nhues P, Sobin LH. (series eds.) World Health Organi-\nzation Classification of Tumours. Lyon: IARCPress, \n2000:104."},{"issue":"7","key":"ref25","article-title":"AJCC cancer staging manual","author":"SEdgeS","year":"2010","unstructured":"Edge SB, Byrd DR, Compton CC, Fritz AG, Greene \nFL, Trotti A, editors. AJCC cancer staging manual \n(7th ed). New York: Springer-Verlage, 2010."},{"key":"ref26","first-page":"985132","article-title":"Matrix metalloproteinases and tissue inhibitor of metalloproteinases are essential for the inflammatory response in cancer cells","author":"JSunJ","year":"2010. 2010","unstructured":"Sun J. Matrix metalloproteinases and tissue inhibitor \nof metalloproteinases are essential for the inflamma-\ntory response in cancer cells. J Signal Transduct 2010; \n2010:985132.","journal-title":"J Signal Transduct"},{"key":"ref27","first-page":"2519","article-title":"Prognostic and predictive molecular markers in colorectal carcinoma","author":"RBendardafR","year":"2004","unstructured":"Bendardaf R, Lamlum H, Pyrh\u00f6nen S. Prognostic and \npredictive molecular markers in colorectal carcino-\nma. Anticancer Res 2004; 24:2519-30.","journal-title":"Anticancer Res"},{"key":"ref28","first-page":"157","article-title":"Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets","author":"PVihinenP","year":"2002","unstructured":"Vihinen P, K\u00e4h\u00e4ri V. Matrix metalloproteinases in \ncancer: prognostic markers and therapeutic targets. \nInt J Cancer 2002; 99:157-66.","journal-title":"Int J Cancer"},{"key":"ref29","first-page":"41839","article-title":"Progressive increase of matrix metalloprotease-9 and interleukin-8 serum levels during carcinogenic process in human colorectal tract","author":"FBiasiF","year":"2012","unstructured":"Biasi F, Guina T, Maina M, Nano M, Falcone A, \nAroasio E, Saracco GM, Papotti M, Leonarduzzi G, \nPoli G. Progressive increase of matrix metalloprote-\nase-9 and interleukin-8 serum levels during carcino-\ngenic process in human colorectal tract. PLoS ONE \n2012; 7: e41839.","journal-title":"PLoS ONE"},{"key":"ref30","first-page":"5649","article-title":"AACR centennial series: the biology of cancer metastasis: historical perspective","author":"JTalmadgeJ","year":"2010","unstructured":"Talmadge JE, Fidler IJ. AACR centennial series: the \nbiology of cancer metastasis: historical perspective. \nCancer Res 2010; 70:5649-69.","journal-title":"Cancer Res"},{"key":"ref31","first-page":"1149","article-title":"Assessing the value of matrix metalloproteinase 9 (MMP9) in improving the appropriateness of referrals for colorectal cancer","author":"SDameryS","year":"2013","unstructured":"Damery S, Nichols L, Holder R, Ward ST, Warm-\nington S, Wilson S, Wakelam MJ, James J, Ismail \nT. Assessing the value of matrix metalloproteinase 9 \n(MMP9) in improving the appropriateness of referrals \nfor colorectal cancer. Br J Cancer 2013; 108:1149-56.","journal-title":"Br J Cancer"},{"key":"ref32","first-page":"703","article-title":"Levels of matrix metalloproteinases differ in plasma and serum -aspects regarding analysis of biological markers in cancer","author":"AJonssonA","year":"2016","unstructured":"Jonsson A, Hjalmarsson C, Falk P, Ivarsson ML. Le-\nvels of matrix metalloproteinases differ in plasma and \nserum -aspects regarding analysis of biological mar-\nkers in cancer. Br J Cancer 2016; 115:703-6.","journal-title":"Br J Cancer"},{"key":"ref33","first-page":"13240","article-title":"The behavior of matrix metalloproteinases and their inhibitors in colorectal cancer","author":"LHersz\u00e9nyiL","year":"2012","unstructured":"Hersz\u00e9nyi L, Hritz I, Lakatos G, Varga MZ, Tula-\nssay Z. The behavior of matrix metalloproteinases \nand their inhibitors in colorectal cancer. Int J Mol Sci \n2012; 13:13240-63.","journal-title":"Int J Mol Sci"},{"key":"ref34","first-page":"1022","article-title":"Genetic polymorphisms of matrix metalloproteinases and clinical outcomes in colorectal cancer patients","author":"WTingW","year":"2013","unstructured":"Ting WC, Chen LM, Pao JB, Yang YP, You BJ, Chang \nTY, Lan YH, Lee HZ, Bao BY. Genetic polymorphi-\nsms of matrix metalloproteinases and clinical outco-\nmes in colorectal cancer patients. Int J Med Sci 2013; \n10:1022-7.","journal-title":"Int J Med Sci"},{"key":"ref35","first-page":"32","article-title":"Prognostic values of matrix metalloproteinase family expression in human colorectal carcinoma","author":"TAsanoT","year":"2008","unstructured":"Asano T, Tada M, Cheng S, Takemato N, Kuramae T, \nAbe M, Takahashi O, Miyamato M, Hamada J, Mo-\nriuchi T, Kondo S. Prognostic values of matrix me-\ntalloproteinase family expression in human colorectal \ncarcinoma. J Surg Res 2008; 146:32-42.","journal-title":"J Surg Res"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/jso.21462","article-title":"Metalloproteinases and their regulators in colorectal cancer","author":"MfpVan Der JagtMfp","year":"2010","unstructured":"van der Jagt MFP, Wobbes T, Strobbe LJA, Sweep \nFCGJ, Span PN. Metalloproteinases and their regula-\ntors in colorectal cancer. J Surg Oncol 2010; 101:259-\n69.","journal-title":"J Surg Oncol"},{"key":"ref37","first-page":"101","article-title":"Role of matrix metalloproteinases (MMPs) in colorectal cancer","author":"SZuckerS","year":"2004","unstructured":"Zucker S, Vacirca J. Role of matrix metalloproteina-\nses (MMPs) in colorectal cancer. Cancer Metastasis \nRev 2004; 23:101-17.","journal-title":"Cancer Metastasis Rev"},{"key":"ref38","first-page":"366","article-title":"The role of matrix metalloproteinases in colorectal cancer","author":"ASaidA","year":"2014","unstructured":"Said AH, Raufman J-P, Xie G. The role of ma-\ntrix metalloproteinases in colorectal cancer. Can-\ncers 2014; 6:366-75.","journal-title":"Cancers"}],"container-title":["Medicinski Glasnik"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/medicinskiglasnik.ba\/article\/73\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/medicinskiglasnik.ba\/article\/73\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T09:43:41Z","timestamp":1775468621000},"score":1,"resource":{"primary":{"URL":"https:\/\/medicinskiglasnik.ba\/article\/id\/96\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,1]]},"references-count":38,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2017,8,1]]},"published-print":{"date-parts":[[2017,8,1]]}},"URL":"https:\/\/doi.org\/10.17392\/908-17","archive":["Internet Archive"],"relation":{},"ISSN":["1840-0132","1840-0132"],"issn-type":[{"value":"1840-0132","type":"electronic"},{"value":"1840-0132","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8,1]]}}}